文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛儿科与产科急症

血清乳酸与儿童院外心脏骤停后结局的关联:THAPCA试验二次分析

Association of serum lactate with outcome after pediatric out-of-hospital cardiac arrest: a secondary analysis of the Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) trial.
PubMed 文献 · Resuscitation · 2026-06-18
一句话结论儿童院外心脏骤停复苏后6小时内乳酸升高与12个月不良神经行为结局或死亡相关,每升高1 mmol/L比值比增加1.40。

该研究为THAPCA-OH试验的二次分析,纳入213例在自主循环恢复(ROSC)后24小时内有至少一次乳酸测量的患儿。主要终点为12个月不良神经行为功能或死亡。结果显示,12个月不良结局组乳酸中位数7.8 mmol/L,显著高于良好结局组的3.1 mmol/L(差值4.8,95%CI 3.7-5.9);院内死亡组乳酸中位数8.6 mmol/L,高于存活组的3.6 mmol/L(差值5.1,95%CI 4.0-6.1)。乳酸每升高1 mmol/L,12个月不良结局的比值比增加1.40(95%CI 1.17-1.69)。作者认为乳酸可能作为早期神经预后和死亡预测的辅助指标。

要点

  • 在THAPCA-OH试验人群中,ROSC后6小时内乳酸升高与12个月不良神经行为结局或死亡独立相关,每升高1 mmol/L比值比1.40(95%CI 1.17-1.69)。
  • 12个月不良结局患儿ROSC后6小时内乳酸中位数为7.8 mmol/L,良好结局患儿为3.1 mmol/L,差值4.8 mmol/L(95%CI 3.7-5.9)。
  • 院内死亡患儿乳酸中位数为8.6 mmol/L,存活患儿为3.6 mmol/L,差值5.1 mmol/L(95%CI 4.0-6.1)。
  • 首次(6小时内)与峰值(12或24小时内)乳酸的AUROC相似,作者选择报告ROSC后6小时内首次乳酸的分析结果。
  • 作者认为乳酸有潜力作为儿童心脏骤停后早期神经预后和死亡预测的辅助生物标志物。

适用人群与场景

  • THAPCA-OH试验中在ROSC后24小时内有至少一次乳酸测量的儿童院外心脏骤停患者。

研究设计与关键结果

  • 研究类型:THAPCA-OH随机对照试验的二次分析;样本量213例;82%出现主要不良结局。
  • 主要终点:12个月不良神经行为功能或死亡;乳酸与所有结局强相关,不同时间点AUROC相似。
  • 12个月不良结局组乳酸中位数7.8 mmol/L vs 良好结局组3.1 mmol/L,差值4.8(95%CI 3.7-5.9)。
  • 院内死亡组乳酸中位数8.6 mmol/L vs 存活组3.6 mmol/L,差值5.1(95%CI 4.0-6.1)。
  • 乳酸每升高1 mmol/L,12个月不良结局的比值比1.40(95%CI 1.17-1.69)。

证据类型、等级与局限

  • 证据类型:随机对照试验(THAPCA-OH)的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为乳酸有潜力作为儿童院外心脏骤停后早期神经预后和死亡预测的辅助指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Neuroprognostication after pediatric out-of-hospital cardiac arrest (OHCA) is challenging. Serum lactate has potential as an adjunct biomarker. We examined the association of lactate measurements with 12-month neurobehavioral outcomes and hospital mortality in a secondary analysis of the Therapeutic Hypothermia After Pediatric Cardiac Arrest Out-of-Hospital (THAPCA-OH) trial.

METHODS: Study participants with at least one lactate measurement (mmol/L) within 24-h of return of spontaneous circulation (ROSC) were included. The primary outcome was unfavorable neurobehavioral functioning or death at 12-months. Univariable, multivariable and area under the receiver operator characteristic curve (AUROC) analyses were performed at four timepoints: first lactate within 6 or 12-h, and peak lactate within 12 or 24-h of ROSC.

RESULTS: The primary analysis included 213 patients, 82% of which had a primary unfavorable outcome. AUROCs showed strong association of lactate with all outcomes and were similar between timepoints, thus we reported the analyses of first lactate within 6 h of ROSC. Median lactate measurements were higher among those with primary unfavorable versus favorable 12-month outcome (7.8 versus 3.1, difference [95%CI]: 4.8[3.7-5.9]) and those who died in the hospital versus survivors (8.6 versus 3.6, difference [95%CI]: 5.1[4.0-6.1]). For each lactate increase of 1 mmol/L, odds (95%CI) of primary unfavorable outcome at 12-months increased 1.40 (1.17, 1.69).

CONCLUSION: Among subjects enrolled in the THAPCA-OH trial, higher lactates within 6-h of ROSC were associated with unfavorable outcome at one year. Lactate has potential as an adjunct for early neuroprognostication and mortality prediction.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Schmidt CD, Carlton EF, Page K, et al. Association of serum lactate with outcome after pediatric out-of-hospital cardiac arrest: a secondary analysis of the Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) trial. Resuscitation. 2026. PMID: 42314897. doi:10.1016/j.resuscitation.2026.111178

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。